Eric C. Hsu - Oct 18, 2021 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Sr. VP, Pre-Clinical Res/Dev
Signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Eric C. Hsu
Stock symbol
INM
Transactions as of
Oct 18, 2021
Transactions value $
$0
Form type
4
Date filed
10/19/2021, 06:22 PM
Next filing
Nov 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +35K +42.7% $0.00 117K Oct 18, 2021 Common shares 35K $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.